Hester Biosciences has informed that Hester Biosciences (Hester India) has entered into a Shareholder's Agreement, Share Purchase Agreement and Share Subscription Agreement (collectively referred to as Transactional Documents) to: Acquire 486 equity shares of Thrishool Exim Limited (TEL), Tanzania from the existing promoters; and subscribe 1,188 equity shares of TEL. Thereby, acquire and subscribe a total of 1,674 equity shares representing 50% of total issued and paid-up equity share capital of TEL. The background of TEL is mentioned as point number 10 in the Annexure 1. The aforesaid Transaction Agreements are subject to customary conditions precedent and receipt of approvals as listed in Annexure 1 hereto.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: